Journal
ANTIOXIDANTS
Volume 10, Issue 5, Pages -Publisher
MDPI
DOI: 10.3390/antiox10050725
Keywords
nanocarriers; safety; biofilm; wound closure; oxidative stress; TNF alpha; VEGF
Funding
- University Grant Commission under UGC- RFMS (Research Fellowship in Sciences for Meritorious Students) [F.4-1/2006 (BSR)/594/2007 (BSR)]
- Countermeasures Against Chemical Threats, NIH [U54AR055073]
- Center for Dermal Research CDR, Rutgers, the State University of New Jersey, Piscataway, NJ, USA
Ask authors/readers for more resources
This study aimed to develop high drug-loaded curcumin solid lipid nanoparticles (CSLNs) for wound healing, showing superior drug release properties and antimicrobial effects. The CSLNs exhibited excellent safety, stability, controlled release, and disruption of mature biofilms, both in vitro and in vivo.
The study aims to develop high drug-loaded (about 15% lipid matrix) curcumin solid lipid nanoparticles (CSLNs) for wound healing. CSLNs prepared by hot, high-pressure homogenization, without using organic solvents, were optimized using the Taguchi design followed by the central composite design. The optimized CSLNs exhibited a high assay/drug content (0.6% w/w), solubility (6 x 10(5) times), and EE (75%) with a particle size < 200 nm (PDI-0.143). The CSLNs were safe (in vitro and in vivo), photostable, autoclavable, stable up to one year at 30 degrees C and under refrigeration and exhibited a controlled release (zero-order; 5 days). XRD, FTIR, and DSC confirmed solubilization and entrapment of the curcumin within the SLNs. TEM and FESEM revealed a smooth and spherical shape. The CSLNs showed a significant antimicrobial effect (MIC of 64 mu g/mL for planktonic cells; 512 mu g/mL for biofilm formation; and 2 mg/mL for mature biofilm) against Staphylococcus aureus 9144, while free curcumin dispersion did not exhibit any effect. This is the first report on the disruption of mature biofilms by curcumin solid lipid nanoparticles (CSLNs). The cell proliferation potential of CSLNs was also evaluated in vitro while the wound healing potential of CSLNs (incorporated in a hydrogel) was assessed in vivo. In (i) nitrogen mustard gas and (ii) a full-thickness excision wound model, CSLNs exhibited (a) significantly faster wound closure, (b) histologically and immunohistochemically better healing, (c) lower oxidative stress (LPO) and (d) inflammation (TNF alpha), and (e) increased angiogenesis (VEGF) and antioxidant enzymes, i.e., catalase and GSH levels. CSLNs thus offer a promising modern wound therapy especially for infected wounds, considering their effects in mature biofilm disruption.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available